| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fc19d8d6ba9ad5c1fa5770341472b56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c525959c1dbfc1200f0645c5eade13d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90734892edbd185b68f67905accc5a2d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
| filingDate |
1999-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de647657abb447172f12cf9df787da7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_996bfa22cf567d21c9fc44d7b8d3b867 |
| publicationDate |
1999-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9951272-A1 |
| titleOfInvention |
Injectable igf-formulations containing succinate as buffering agent |
| abstract |
The invention is directed to formulations of a pharmaceutically active agent for in vivo use. The formulations to which the invention is directed are designed to minimize the pain associated with components in injectable formulations, other than the pharmaceutically active agent. The invention is particularly directed to buffers that provide for minimum pain upon injection. Insulin-like growth factor I (IGF-I) is a preferred pharmaceutically active agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03024471-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7030086-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7807142-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03024471-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7892531-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7371373-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7399463-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6887462-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8333958-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6525102-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7534765-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7659248-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7368115-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7393830-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7604993-B2 |
| priorityDate |
1998-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |